Related Articles
Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity
Effect of additional inhibition of human epidermal growth factor receptor 2 with the bispecific tyrosine kinase inhibitor AEE788 on the resistance to specific EGFR inhibition in glioma cells
Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model
HER2 regulates cancer stem-like cell phenotype in ALK translocated NSCLC
The combination of NVP-BKM120 with trastuzumab or RAD001 synergistically inhibits the growth of breast cancer stem cells in vivo